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Three-dimensional in vivo characterization of calcification
in native valves and in Freestyle versus homograft aortic
valves
Giovanni Melina, PhD,a Paramate Horkaew,b Mohamed Amrani, FRCS,a Michael B. Rubens, FRCR,a
Magdi H. Yacoub, FRS,a and Guang-Zhong Yang, PhDb
Objective: This article describes a novel interactive method for quantitative evalu-
ation of calcium deposits in the aortic valve by means of electron beam tomography
data fusion technique.
Methods: The technique relied on the use of hierarchic 3-dimensional free-form
volume registration with fast global optimization between normally acquired and
contrast-enhanced electron beam tomographic volume. A total of 66 contrast-
enhanced electron beam tomographic scans of the aortic root were performed in 27
patients, 10 with native aortic valve disease (group A) and 17 from a prospective
randomized trial of aortic root replacement (group B, 9 Freestyle grafts [Medtronic,
Inc, Minneapolis, Minn] and 8 homografts). To validate the in vivo electron beam
tomographic measurements, 5 patients from group A underwent electron beam
tomographic scans before the operation and then had their own valves, explanted at
the time of surgery, analyzed for calcium quantification by ex vivo electron beam
tomography.
Results: In group A, the mean ( SE) calcification score was 6560  2388, which
correlated with peak gradients measured at echocardiography (r  0.93, P  .02).
In group B, the mean ( SE) calcification score was 168  27, showing a tendency
toward a lower calcification for Freestyle valves than for homografts at 2 years after
implantation (P  .052). A mean variability of 6% was found between in vivo
electron beam tomographic scores of calcification and those measured on valve
specimens after explantation.
Conclusion: We describe a novel method to characterize the degree and location of
calcification in both native valves and postoperative valve implants. The technique
may be useful in the management of patients with aortic valve disease and has
potential as a screening tool for high-risk patients to diagnose early valve calcifi-
cation and possibly institute corrective measures.
Calcific aortic stenosis is the most common valve disease in elderly patientsin Europe and the United States, and its incidence is rapidly rising.1,2Factors implicated in atherosclerosis may contribute to valve calcification
and therefore may be amenable to institution of therapeutic measures.3 In a recent
prospective study of a series of symptom-free patients with severe aortic stenosis,
the degree of calcification of the native aortic valve has been shown to be a
determinant of prognosis and outcome.4 In addition, calcification of valve biopros-
theses is thought to play a crucial role in their failure.5 Thus availability of a rapid
and reliable technique for accurately quantifying the degree and pattern of calcifi-
cation could play a major role in the management of both groups of patients and
possibly serve as a screening tool for “high-risk” patients. Electron beam tomog-
raphy (EBT) has been widely used to detect calcium in the coronary arteries6,7 and
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the aortic wall.8,9 A recent investigation10 with a computed
tomographic (CT) technique demonstrated the pattern of
calcification and graded the amount of calcium of the aortic
valve, but that study was undertaken in patients with ad-
vanced calcific aortic stenosis and has not been validated.
Similarly, Shavelle and associates11 used EBT to retrospec-
tively quantify aortic valve calcification in patients who
underwent EBT scanning to evaluate coronary artery cal-
cium. They also demonstrated a threshold amount of EBT
aortic valve calcification above which the probability of
aortic stenosis is high.11 In addition, the group from Mayo
Clinic have shown the prognostic value of EBT in detecting
and quantifying calcium in the aortic valve.12 However,
routine CT techniques are not able to localize the aortic
valve leaflets unless they are heavily calcified because of the
movement of the leaflets and aortic ring during different
phases of the cardiac cycle.13 To address this, we have
previously described a method that uses contrast enhance-
ment EBT to localize the valve cusps on one occasion,
which enables repeated scans after that.14 In addition, we
have recently validated the EBT technique with both exper-
imental15 and human explanted bioprostheses.16 In this
study, we aimed to refine and extend our previous method14
to quantify and localize calcium deposits with a rapid 3-
dimensional (3D) image registration technique in both na-
tive and postoperative bioprosthetic aortic valve leaflets.
Methods
Patient Population and EBT Image Acquisition
A total of 27 patients (age range 45-77 years) were investigated for
EBT detection and quantification of calcium deposits in the aortic
valve leaflets. This included 10 patients (group A) with aortic
valve disease (stenosis in 6 and regurgitation in 4) and 17 postop-
erative patients (group B) from a prospective randomized trial of
Medtronic Freestyle (Medtronic, Inc, Minneapolis, Minn) versus
homograft root replacement9 at the Royal Brompton and Harefield
National Health Service Trust (London, UK). In group B, 9 pa-
tients received Freestyle bioprostheses, and 8 received homograft
valves. The local ethics committee approved the study protocol,
and all participating patients gave written, informed consent to the
investigation. EBT scans of the aortic root were performed before
the operation in group A and at 6-monthly intervals after aortic
root replacement in group B. The operative technique has been
previously described.9 The clinical and demographic characteris-
tics of the study population are listed in Table E1. In addition, a
subset of 5 patients from group A undergoing aortic valve replace-
ment had their diseased aortic valves carefully explanted at the
time of surgery in an attempt to include all cusp calcification in one
intact, excised specimen. The valve specimens so obtained were
subsequently analyzed by EBT for calcium quantification, and the
calcium scores thus measured were compared with those previ-
ously determined in vivo before the operation.
Before their scans, all patients were investigated regarding any
known allergy, even though they had previously undergone cardiac
catheterization with a larger amount of contrast medium as a
routine investigation for their coronary arteries and possibly aortic
valve pathology. Renal function was routinely checked for each
patient.
For the in vivo EBT, a set of 20 to 25 transverse tomograms of
3-mm thickness was obtained through the aortic root with the
subject breath holding. Acquisitions were made at 80% of the RR
interval. The scan was then repeated during intravenous injection
of a contrast medium. Omnipaque 240 (Nycomed Imaging AS,
Oslo, Norway) was injected into a vein in the antecubital fossa at
a rate of 3 mL/s, and scans were acquired at 30 seconds after the
beginning of the injection. The explanted native aortic valves were
analyzed in accordance with our previous studies.15,16
Echocardiographic Measurements
Transthoracic echocardiograms were performed at same time in-
tervals as the EBT investigations by means of a Hewlett Packard
Sonos (Hewlett-Packard Ltd, Bracknell, UK) machine. Echocar-
diographic Doppler imaging was used to analyze transvalvular and
subvalvular flows. Peak transvalvular and subvalvular flow veloc-
ities were recorded, and gradients were derived with the modified
Bernoulli equation: P  4v2. Mean gradients were calculated
from the flow profile.
EBT 3D Serial Image Registration
The examinations were based on a sequential back-to-back scan.
To circumvent the geometric inconsistencies introduced by the
respiratory movements of the base of the heart during the cardiac
cycle, we adapted a previously developed rapid intensity–based mul-
tiresolution image registration scheme.17 As extended from the pre-
vious study,17 a free-form image registration based on 3D B-spline
transformation model was adopted to correct the respiration-induced
cardiac deformation. In this study, intensity based cross-correlation
coefficient was used as a measure of the degree to which the two
images were aligned. The optimal B-spline parameters to maximize
this similarity measure were determined with a multihierarchical
quasi-Newton optimization strategy.17 The definition of the cross-
correlation coefficient and a detailed optimization strategy for image
registration are described in Appendix E1.
Interactive Volume Visualization and Calcium Scoring
For interactive volume visualization of the general trends of valve
calcification with time, a software-accelerated 3D interactive ren-
dering technique called the “bubble model” with shear-warp fac-
torization was used. The normally scanned volume was segmented
with calcium-level thresholding (130 Hounsfield units) with iso-
surface rendering.
For quantitative analysis, interactive calcium quantification was
conducted with CMRTools (Imperial College, London, UK) ac-
cording to the Agatston scoring scheme.6,9 Two uninformed, in-
dependent observers (G.M and P.H.) were asked to interactively
identify the location of the calcified leaflets and define regions of
interest on the enhanced images showing the exact location of the
valve leaflets. These regions of interest were then automatically
overlaid on the corresponding unenhanced ones for calculation of
the calcium score. A calcium score was then calculated for each
valve by multiplying the calcified lesion area in square millimeters
by a density score determined from the peak CT number. For each
observer, the process was repeated twice. Both interobserver and
intraobserver variabilities were calculated. In addition, on the basis
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of the free-form registration results, each aortic valve was normal-
ized as a circular disk with sectors labeled as right, left, and
noncoronary leaflets, respectively. For each subject, calcified le-
sions were spatially mapped onto the disk according to their actual
locations on the leaflets. The use of this normalizing scheme not
only facilitates intrasubject follow-up assessment but also simpli-
fies localization comparisons. Calcium within aortic sinuses, aortic
wall, or both was carefully excluded from the analysis.
Statistical Analysis
Continuous variables were analyzed by means of the Student t test
for unpaired data as appropriate. A 2-way analysis of variance was
used to assess serial changes in continuous variables. Correlations
between the calcification scores and peak transvalvular gradients
were determined by means of Pearson product-moment correlation
analysis.
Results
Image Registration
Figure E1 shows a single image slice through the 3D vol-
ume of a patient, illustrating both the conventional (Figure
E1, A) and contrast-enhanced (Figure E1, B) EBT images.
In Figure E1, A, the calcified region, in this case mainly on
the aortic wall, is well defined. Because of similar X-ray
attenuation in blood and the aortic cusps, the valvular region
is not clearly visible. The injection of the contrast agent
(Figure E1, B) enhances the attenuation difference and
makes the aortic leaflets clearly delineated. Because of the
inconsistencies between different breath-holds and discrep-
ancies in patient alignment between serial examinations,
Figure E1, C, demonstrates the misregistration artifact be-
tween the contrast-enhanced 3D volume and one of the
serial scans. A composite color scheme of green and ma-
genta is used. When two images are in alignment, the
overlay image should generally be in gray.
Figure E2 shows examples of color overlay of the normal
and contrast-enhanced images before (Figure E2, A) and
after (Figure E2, B) registration at three consecutive slice
locations. It is evident that calcium deposits can be clearly
identified around the aortic cusps after registration.
Calcium Quantification
The native dysfunctional aortic valves in group A had
calcium scores from 235 to 16,332. The interobserver vari-
ability was 4%, and the intraobserver variabilities were
2.2% and 2.5%. Mean ( SE) calcium scores were 10,586
 3001 (mean  SE gradient 78  3 mm Hg) for patients
with aortic stenosis and 523  177 for patients with aortic
regurgitation (mean  SE gradient 21  1 mm Hg).
The quantitative results for the 17 patients in group B are
provided in Figure 1. There was a trend for calcification to
increase with time in the homografts but not in the Freestyle
valves. For the total 122 volume pairs analyzed, the inter-
observer variability was 9.2%, and intraobserver variabili-
ties were 18% and 13.5%.
The calcium scores measured before the operation in the
subset of 5 patients from group A varied from 870 to
16,332. The calcium quantification made on their own
valves explanted during the operation showed scores vary-
ing from 771 to 15,239, which gave a mean variability of
6% relative to those previously calculated in vivo.
Calcium Localization
Figure 2 shows the calcium content for each cusp (right,
left, and noncoronary) with time in all the patients from
group B. Interestingly, the left coronary leaflet showed a
higher degree of calcification than did the right and non-
coronary leaflets at each time point.
Figure 1. Calcification trend in patients who received biopros-
thetic valves (homograft or Medtronic Freestyle). Figure 2. Calcium contents of left, right, and noncoronary cusps
for all patients who underwent aortic valve replacement.
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As shown in two samples in Figure 3, calcification was
localized mainly at the base of the leaflets in the area of the
native aortic annulus, corresponding to the proximal suture
line in the group of patients who underwent aortic root
replacement. In the homograft group, spots of calcification
were widely detected in the belly of the leaflets at the latest
EBT scan, particularly affecting the base (Figure E3, A). In
the Freestyle group, minor degrees of calcification, which
did not increase with time, remained localized at the suture
line, with much smaller areas of calcification than in the
homograft group in the belly of the cusp (Figure E3, B).
The native valves showed a higher degree of calcification
of the three cusps (Figure E3, C). In this group, extensive
calcification was found at the base of the leaflets, the belly,
including the coaptation surface and at the three commis-
sures (Figure E3, C).
Relation to Hemodynamic Data
In group A (n  10), the mean peak transvalvular gradient
measured at echocardiography was 54 mm Hg, and it cor-
related well with the scores of calcification (r  0.94, P 
.02), with the highest calcification score to cause significant
stenosis being 16,332. No patient in group B (n  17)
showed pathologic gradients across the aortic valve. The
mean gradients were always less than 3 mm Hg, and the
echocardiographic investigations demonstrated a good leaf-
let excursion during the cardiac cycle at each interval. The
highest calcification score in group B was 821.
Discussion
This study describes a novel, rapid, 3D method of serial
assessment of the amount and localization of calcium de-
posits in both native and bioprosthetic aortic valves. The
technique requires a single contrast-enhanced baseline 3D
tomographic volume for aligning subsequent conventional
EBT scans that follow the development of calcified regions.
The preliminary results from 27 patients demonstrate the
technique’s potential clinical use for calcium quantification
in both native and bioprosthetic aortic valves. In addition,
Figure 3. 3D rendering of overlaid volumes showing calcification after operation in homograft (A) and Medtronic
Freestyle valve (B).
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we have validated the use of this method for quantifying in
vivo aortic valve calcification in human beings.
The aortic valve performs sophisticated functions, which
are dependent on the dynamic behaviors of its compo-
nents.18 Calcific stenosis is a common failure mode for both
native human aortic valves and the biologic aortic biopros-
theses, but in neither case are the etiology and mechanism of
progression well understood. In native valves, calcification
is an active process resembling atherosclerosis.3,19 The cal-
cification process has some similarities in glutaraldehyde-
fixed bioprosthetic valves, but it does not involve living
interstitial cells because glutaraldehyde is cytotoxic. In ad-
dition, free aldehyde within the tissue matrix has also been
thought to be an indicator for calcification.20 The biome-
chanical environment within which the bioprosthetic valve
is placed determines the underlying trend that the structure
is altered both morphologically and functionally. Existing
research in the area underscores the complexity of the
bioprosthetic valve calcification process and highlights the
need for combined biochemical, genetic, biomechanical,
histologic, and accurate in vivo imaging studies. The
method described in this article could help in that regard.
EBT has proved to be highly sensitive for calcium mea-
surements in the coronary arteries,21 and it has the advan-
tage of being noninvasive, allowing a rapid acquisition of
the images. By using EBT, we demonstrated the pattern of
calcification of the aortic root wall after aortic root replace-
ment with homografts or Medtronic Freestyle porcine xeno-
grafts.9 The technique was then improved for the visualiza-
tion of the aortic valve leaflets.14 In two different in vitro
experiments, we then validated our EBT method for detec-
tion and quantification of aortic valve leaflets.15,16 We
found high correlations between the EBT scores and of
biochemically measured calcium content with experimental
valves15 or failed biologic prostheses explanted from pa-
tients.16 The validation of the technique has been extended
in this study, in which there was only a 6% mean variability
between the EBT measures in vivo and the quantification of
calcium on the aortic valve samples after explantation from
the patients during the operation for aortic valve replace-
ment. This variability could have been due, at least in part,
to inability to excise the valve intact with all the calcium.
The quantification of calcium was further improved in this
investigation. We have used a fast, multiresolution 3D
registration scheme based on the piecewise linear joint-
histogram relationship between normally acquired and con-
trast-enhanced volumes. This simplifies the treatment of the
optimization process, which involves a large number of
free variables, and permits the use of Broyden-Fletcher-
Goldfarb-Shanno (BFGS) algorithm, which is an extension
to the Newton method and has a quadratic convergence
property (Appendix E1). It is worth noting that the chosen
similarity function is justified by the use of blood pools as
registration landmarks. The local joint histogram of inten-
sities within the blood pool has been shown to have nearly
linear correlation between the standard and contrast-en-
hanced CT volumes. The abundance of the blood signal at
the imaging volume therefore has a strong influence toward
the correct alignment of both volumes. This patient study
indicates the practical value of the developed method.
Some recent studies have suggested the use of EBT to
detect and quantify calcification of the native aortic
valve.3,22 These studies, however, tended to use scans per-
formed primarily to assess coronary artery calcification3 or
were done in patients undergoing catheterization before
aortic valve replacement or who were found to have at least
mild aortic stenosis at echocardiography22 and therefore did
not take into account the movement of the aortic root, the
position of the aortic cusps, and the different positioning of
the patients on the scanner. These difficulties can be cir-
cumvented by localizing the aortic cusps with contrast en-
hancement on one occasion.14 Shavelle and associates11
showed in a retrospective study that patients with EBT
aortic valve calcification scores of at least 150 should be
referred for echocardiography, because these are more
likely to have significant aortic stenosis.11 In our series of
bioprosthetic valves (both homografts and Freestyle
valves), 8 patients had a calcification score of at least 150 at
different time points, but in none were peak gradients higher
than 7 mm Hg. This rule of thumb, however could be true
for the native valves, where the lowest score was 235 and
the agreement with the echocardiographic gradients across
the aortic valve was high. We think this demonstrates the
importance of the accurate determination of the aortic valve
leaflets and the quantification of calcium by one method.
Calcification is thought to be a major determinant of
hemodynamic function and durability of biologic devices,
which leads to stenosis or regurgitation after implantation.
Localized calcification can alter the physical properties of
the valve and encourage tearing in bioprostheses.
In an attempt to enhance the performance of bioprosthe-
ses, different anticalcification treatments are being used.23,24
Although these techniques have met with success in animal
models, the efficacy in human beings has not been investi-
gated. A quantitative evaluation of the impact of such treat-
ments is therefore needed, and the technique described in
this article provides a powerful tool to achieve this goal. In
addition, the technique allows evaluation of the rate of
progression of calcification in both the native and biopros-
thetic aortic valves and screening of people at risk such as
middle-aged individuals, atherosclerotic patients, patients
undergoing treatment of renal failure, postmenopausal
women, and patients affected by familial hypercholesterol-
emia, which could be of prognostic importance. In addition,
the technique described in this article provides for the first
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time data relating to the in vivo 3D localization of the
calcium deposits in the valve. This provides new additional
data relating to the pattern of calcification in different types
of valves and could help in the understanding of the patho-
genesis of calcification and possibly of its prognosis.
Until recently, the most accurate methods of quantifying
bioprosthetic valve calcification consisted of in vitro anal-
yses such as histologic assessments, radiographic and
atomic absorption spectroscopy, and dual energy x-ray ab-
sorptiometry,25 which did not allow sequential examina-
tions in the same patient. This study, which was conducted
in patients, confirmed that calcification of the bioprosthetic
aortic leaflets occurs as early as 6 months after implantation
for both homografts and Freestyle prostheses. There was a
trend for the calcification to progressively increase in the
homograft group up to 2 years after the operation. The trend
was different in the Freestyle group, where calcification
tended to remain constantly low throughout all the investi-
gation period. The amounts of calcium documented in the
bioprosthetic valves were much lower than those observed
in the diseased native valves. This could be explained by the
fact that the homograft and Freestyle valves studied were
well functioning and had no echocardiographic evidence of
stenosis. However, the progressive accumulation of calcium
in the homografts is a cause for concern and warrants
further investigation. One of the limitations of this study is
that it does not provide information about the dynamics of
the valve leaflets because of the intrinsic constraint of the
imaging modality itself. Recent developments of object-
tracked magnetic resonance imaging26 and 3D ultrasonog-
raphy27 are likely to play an important role in future inves-
tigations in linking mechanical properties to the progression
of valve calcification. Another limitation is that the use of a
contrast medium may be a potential risk for patients with
renal failure and is also a contraindication for allergic
patients.
In conclusion, the technique of in vivo 3D characteriza-
tion of aortic valve calcification described in this article
appears to be a sensitive, reliable method of measuring the
amount and localization of calcification in both native and
bioprosthetic valves. Sequential use of this technique could
be valuable in understanding the pathogenesis of valve
calcification and in the management of patients with aortic
valve disease or bioprosthetic valve replacement.
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Appendix E1. 3D Multiresolution Registration
Extended from our previous study of fast 2-dimensional image
registration, the registration procedure was carried out by using the
cross-correlation coefficients. It was chosen as the similarity mea-
sure because its mathematical formulation can be exploited to
speed up the optimization process, as discussed by Veeser and
colleagues.17 That is:
simI1, I2
  x 
I1xEI1I2xEI2
x I1xEI12x I2xEI22 (1)
where  is the overlapping voxels in the intersection region of
the reference and the transformed volume, E { · } is an expect-
ing function of the voxels intensity, and I1, I2 is the referent and
target images to be registered.
A linear tensor product B-spline defined by equation 2 was
subsequently used as the transformation matrix because it enables
adaptive subdivision of the control grid for a multiresolution
implementation; that is:
Tp
i,j,k
ijku, v, wcijk (2)
where ijk(u,v,w) is the coefficient applied to the point¡p(u,v,w)
cijk is the coordinate of control points surrounding the
point ¡p(u,v,w), and T(¡p) is the transformation that map
point ¡p(u,v,w) in target image to referent image.
A quasi-Newton optimization algorithm, the BFGS algorithm,
was then used to find the optimum transformation parameter
vectors. In contrast to the Newton method, the algorithm does not
need explicit second order derivatives. Instead, it approximates
these values by using information from previous iterations; that is:
x k1 xkHk
1 fxk,
sk xk1 xk, yk  fxk1  fxk,
Hk1Hk
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T
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Tsk

Hksksk
THk
sk
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(3)
where xk is the parameter vector in search space at kth iteration,
f(xk) is the objective function, f(xk) is the vector of partial
derivative of the function with respect to each parameter, and Hk
is the estimated Hessian matrix.
As indicated by equation 3, the BFGS algorithm, however, does
require the evaluation of the first order derivatives of the objective
function, which can be computationally expensive. Fortunately,
with the structure of the similarity matrix, the partial derivatives of
the similarity measure with respect to the control points can be
expressed analytically; that is:
 fc   fc1x0  fc1x1  fc1x2 · · ·  fcnx0  fcnx1  fcnx2	
T
(4A)
where,
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and
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which leads to an efficient implementation of the optimization
strategy.
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Figure E1. One slice of 3D volume before (A) and after (B) contrast enhancements and their superposition (C) with
green-magenta color scheme, showing misregistration artifacts.
Figure E2. Color overlay of three consecutive slices before (A, 1-3) and after (B, 1-3) registration, showing influence
of new method of correcting misregistration (magenta color).
Melina et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 1 47.e2
A
CD
Figure E3. Normalized aortic valve showing localization of calcification in homograft group (A), Freestyle group
(B), and native valve group (C).
TABLE E1. Patient characteristics
Group A Group B
No. of patients 10 17
Age (y)
Mean  SE 62  2 66  2
Range 49-77 45-75
Sex (male/female) 8:2 12:5
Smoking (%) 20 41
Hypertension (%) 40 35
Diabetes (%) 0 0
Renal failure (%) 0 0
Coronary artery disease (%) 20 29
Transvalvular gradient 54  3 6  1
(mm Hg, mean  SE)
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